Is the Bayer-Monsanto Merger Too Big To Succeed?

Bayer, a major pharmaceutical and chemical multinational based in Germany, seeks to expand reach in agriculture and crop science. Its proposed acquisition of Monsanto is “the largest all-cash transaction in history” and a crescendo of “a string of combinations in the industry,” explains David Francis for Foreign Policy. This consolidated corporation would sell approximately one quarter of the world’s seeds and pesticides. The merger confronts roadblocks, including EU and US antitrust regulations as well as intense resistance to genetically modified organisms in Europe. In recent months, the European Commission has investigated tech companies for monopolistic tendencies in their European operations. The Bayer-Monsanto merger would also impact developing nations, where agriculture plays a large role in the economy. Farmers express concern about the potential for high input costs for seeds and low commodity prices when they sell. – YaleGlobal

Is the Bayer-Monsanto Merger Too Big To Succeed?

Amid environmental change, consolidation in agribusiness and biotechnology industries raises worldwide concerns about prices and safety of pesticides and GMO crops
David Francis
Monday, September 19, 2016
Copyright Clearance Center (CCC) is FP’s exclusive agent for granting reprint and reuse permissions.

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.